BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ICON Makes Senior Appointments in Early Phase and Epidemiology & Risk Management


5/21/2012 9:14:07 AM

21st May, 2012 -- ICON plc has made the following appointments:

Dr. Susan Anton, Director, Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research Dr. Susan Anton comes to ICON with over 25 years of experience leading international epidemiologic, health economic, and outcomes research, and other market access initiatives. She joins ICON from Boehringer Ingelheim Pharmaceuticals Inc., where she was Director, US Medical Outcomes Research and Registries. In this role Dr. Anton provided strategic approach, design and analytic guidance for comparative effectiveness research, epidemiologic studies and health technology assessment within their Medical Outcomes Research & Registries division.

Prior to Boehringer Ingelheim, Dr. Anton directed health economic, epidemiologic and outcomes research efforts across therapeutic areas at Bristol-Myers Squibb. Dr. Anton holds a Doctor of Public Health (Epidemiology) and a Master of Public Health from Columbia University, New York.

Dr. Pui Leung, Senior Clinical Research Physician, ICON Development Solutions

Dr Pui Man Leung has joined ICON as Senior Clinical Research Physician at ICON’s Clinical Pharmacology Unit in Manchester, UK.

Dr. Leung joins ICON with over 23 years of hospital and pharmaceutical industry experience in a variety of medical specialties including diabetes, endocrinology and general medicine. Prior to ICON, Dr. Leung gained 10 years of experience as a Senior Phase I Clinical Research Physician in two UK CROs and has been Principal Investigator in many trials with a variety of different study designs including First in Human studies. Before joining the pharmaceutical industry in 2002, Dr. Leung spent 13 years as a hospital physician in the UK’s National Health Service (NHS).

Dr. Leung is a fully qualified Pharmaceutical Physician and is listed in the UK’s Specialist Register in Pharmaceutical Medicine. He is a member of the Royal College of Physicians UK, where he is a member of the Examination Board at the Faculty of Pharmaceutical Medicine. Dr. Leung received his Doctor of Medicine from the University of Aberdeen and studied an MSc by Research in Rheumatology from the University of Manchester.

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 8,500 employees, operating from 81 locations in 40 countries.

Further information is available at www.iconplc.com



Read at BioSpace.com

ICON-PLC
ICON
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES